Statins × quality of life & behaviour

Observational studyJournal of general internal medicine2021

Regularity and Continuity of GP Contacts and Use of Statins Amongst People at Risk of Cardiovascular Events.

David Youens et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 267,153 people · 2021

Not counted

Lowered quality of life & behaviour

−11%−16% to −6%

Bigger than 2 in 10 on the map

As reported

HR 0.89, 95% CI 0.84–0.94

One number in the abstract

the abstract, start to end

continuity group had a hazard ratio of 0.89 (95%CI 0.84-0.94).

← favours treatmentfavours comparator →
could be chance
Quality of life & behaviour
HR 0.890.84–0.94
StatinsQuality of life & behaviour
1 / 3

14 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33655384